Jpmorgan Chase & Co »

Karyopharm Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Karyopharm Therapeutics shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.0M 765k 6.54
2025-03-31 $36k 9.5k 3.74